News

IMBA: PROFILING THE STEM-CELL CHARACTERS IN THE STORY OF STOMACH LINING RENEWAL

Using an unbiased labelling technique, mathematical modelling, and single cell profiling to trace the footsteps of stem...

LISAvienna News

LISAvienna’s August e-Newsletter available now

Our electronic newsletter keeps you up-to-date on the life sciences in Vienna. Today, we highlight news from a:head bio,...

MedUni Vienna: Features of urinary obstruction following kidney transplantation identified for the first time

A research group from the Medical University of Vienna has successfully described the histological features of urinary...

MedUni Vienna: HIV infection increases risk of other health outcomes

People living with HIV are more likely to develop certain other health conditions over the course of their lives. A...

TU Vienna: The formula that makes bacteria float upstream

Until now, it has been unclear how bacteria manage to swim against the current. An international research team has now...

HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics, targeting...

Uni Wien: Vom Röntgenvideo bis zur Gemäldeanalyse

Am 18. August beginnt Europas größte Kristallografie-Konferenz in Wien, mit einem bunten Programm für die breite...

Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

- Initial focus on non-diagnostic testing with Next Generation Sequencing (NGS) for infection control, outbreak...

ITK: Angeborene Immunschwächen in Österreich: Viele Betroffene. Wenig Bewusstsein. 15 Jahre gemeinsames privates Engagement.

Wiener Immunologische Tagesklinik seit 15 Jahren Partner einer einzigartigen US-Stiftung. Vereinter Kampf um bessere...

IMBA: UPCYCLING OF PROTEINS PROTECTS DNA FROM PARASITES

Researchers at IMBA - Institute for Molecular Biotechnology of the Austrian Academy of Sciences – describe “adaptive...

a:head: launched to transform CNS drug discovery

a:head bio AG, an Austrian biotech company focusing on the development of next generation therapeutics for the treatment...

FCIO: Forschungsausgaben der Chemischen Industrie auf Rekordniveau

876 Millionen Euro für die Entwicklung von Innovationen in Chemie und Pharmazie